Breast and Prostate Cancer Data Quality and Patterns of Care (PoC-BP) Study
Started in 2005, the Breast and Prostate Cancer Data Quality and Patterns of Care (PoC-BP) study is the National Program of Cancer Registries' most comprehensive PoC study, involving researchers from CDC and seven states in different geographic areas. The study examines—
- Patterns of initial (first course) treatment received by prostate cancer and female breast cancer patients.
- The extent to which that care is concordant with nationally recognized treatment guidelines.
- How patterns of cancer care vary by patient-, provider-, and health system-level factors.
- The quality of the cancer data for the study.
The routinely collected registry data were supplemented by re-abstracting hospital records and obtaining information about adjuvant treatment and comorbidity from physicians and outpatient facilities. In addition, the study data were linked with secondary files, including Medicare claims, U.S. Census Bureau socioeconomic status data, and hospital/physician characteristics data.
Several manuscripts providing key results have been published in peer-reviewed literature—
Sabatino SA, Thompson TD, Wu XC, Fleming ST, Kimmick GG, Trentham-Dietz A, Cress R, Anderson RT. The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer. Breast Cancer Research and Treatment 2014.
Kimmick GG, Fleming ST, Sabatino SA, Xiao-Cheng W, Hwang W, Wilson JF, Lund MJ, Cress R, Anderson RT. Comorbidity burden and guideline-concordant care for breast cancer. Journal of the American Geriatrics Society 2014;62:482–488.
Wang D, Ho A, Hamilton AS, Wu XC, Lo M, Fleming S, Goodman M, Thompson T, Owen J. Type and dose of radiotherapy used for initial treatment of non-metastatic prostate cancer. Radiation Oncology 2014;9(1):47.
Fleming ST, Hamilton AS, Sabatino SA, Kimmick GG, Wu XC, Owen JB, Huang B, Hwang W. Treatment patterns for prostate cancer: comparison of Medicare claims data to medical record review. Medical Care 2012.
Hamilton AS, Wu XC, Lipscomb, J, Fleming ST, Lo M, Wang D, Goodman M, Ho A, Owen JB, Rao C, German RR. Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer. Journal of the National Cancer Institute Monographs 2012;2012(45):213–220.
Fleming ST, Kimmick GG, Sabatino SA, Cress RD, Wu XC, Trentham-Dietz A, Huang B, Hwang W, Liff JM; Patterns of Care Study Group. Defining care provided for breast cancer based on medical record review or Medicare claims: information from the Centers for Disease Control and Prevention Patterns of Care Study. Annals of Epidemiology 2012;22(11):807–813.
Wu XC, Lund MJ, Kimmick GG, Richardson LC, Sabatino SA, Chen VW, Fleming ST, Morris CR, Huang B, Trentham-Dietz A, Lipscomb J. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. Journal of Clinical Oncology 2012;30(2):142–150.
German RR, Wike JM, Bauer KR, Fleming ST, Trentham-Dietz A, Namiak M, Almon L, Knight K, Perkins C, Patterns of Care Study Group. Quality of cancer registry data: findings from CDC-NPCR's Breast and Prostate Cancer Data Quality and Patterns of Care Study. Journal of Registry Management 2011;38(2):75–86.
Fleming ST, Sabatino SA, Kimmick G, Cress R, Wu XC, Trentham-Dietz A, Huang B, Hwang W, Liff J. Developing a claim-based version of the ACE-27 comorbidity index: a comparison with medical record review. Medical Care 2011;49(8):752–760.
- Centers for Disease Control and Prevention
Division of Cancer Prevention and Control
c/o CDC Warehouse
3719 N Peachtree Rd
Building 100 MS F-76
Chamblee GA 30341
TTY: (888) 232-6348
- Contact CDC-INFO